Citation Impact
Citing Papers
Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART I
2016 Standout
ESUR prostate MR guidelines 2012
2012 Standout
Clinical Efficacy, Safety and Tolerability of Collagenase Clostridium Histolyticum for the Treatment of Peyronie Disease in 2 Large Double-Blind, Randomized, Placebo Controlled Phase 3 Studies
2013 Standout
Outcomes Following Endovascular vs Open Repair of Abdominal Aortic Aneurysm<subtitle>A Randomized Trial</subtitle>
2009 Standout
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
2016 Standout
Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction
2003
Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
2008 Standout
Nitric oxide/redox-based signalling as a therapeutic target for penile disorders
2006
Reassessing the value of varicocelectomy as a treatment for male subfertility with a new meta-analysis
2007
Guidelines on Urolithiasis<footref rid="foot01"><sup>1</sup></footref>
2001 Standout
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
Phosphodiesterase-5 Inhibition: the Molecular Biology of Erectile Function and Dysfunction
2005
Inventory of prostate cancer predictive tools
2008
Comparison between Open Partial and Radical Nephrectomy for Renal Tumours: Perioperative Outcome and Health-Related Quality of Life
2006
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
2009 Standout
Shock Wave Lithotripsy-Induced Renal Injury
1991
Female sexual dysfunction in a population-based study in Iran: prevalence and associated risk factors
2006
Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents
2005 Standout
Heating the patient: a promising approach?
2002 Standout
Tranexamic Acid
2012
Harmless Herbs? A Review of the Recent Literature
1998 Standout
Sexual Dysfunction in Parkinson's Disease
2004
Antidepressants and sexual dysfunction
2006
The Risk–Benefit Profile of Commonly Used Herbal Therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava
2002 Standout
Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial
2005
Cushing's syndrome
2015 Standout
Nomograms in oncology: more than meets the eye
2015 Standout
The impact of urinary incontinence on female sexual function
2006
Phaeochromocytoma
2005 Standout
α1‐, α2‐ and β‐adrenoceptors in the urinary bladder, urethra and prostate
2006
Sexual Problems and Distress in United States Women
2008 Standout
Nelson's syndrome
2010
Prostate Cancer: Sextant Localization with MR Imaging, MR Spectroscopy, and11C-Choline PET/CT
2007
Imaging of prostate cancer local recurrences: why and how?
2009
Radiation Therapy for Cushing's Disease: A Review
2002
Sexual Dysfunction After Conventional and Endovascular AAA Repair:Results of the DREAM Trial
2004
The Role of a Combined Regimen With Intravesical Chemotherapy and Hyperthermia in the Management of Non-muscle-invasive Bladder Cancer: A Systematic Review
2011
Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging
2008
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non–Muscle-invasive Bladder Cancer
2016
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013
2013 Standout
Serenoa repens for benign prostatic hyperplasia
2002
Bilateral adrenalectomy for Cushing’s syndrome: A comparison between laparoscopy and open surgery
2004
Cushing's syndrome
2001
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
Chronic sildenafil in men with diabetes and erectile dysfunction
2007
Population‐based comparative effectiveness of nephron‐sparing surgery vs ablation for small renal masses
2012
Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement
2003 Standout
A Review of 12 Commonly Used Medicinal Herbs
1998
Surgical Correction of Peyronie's Disease via Tunica Albuginea Plication or Partial Plaque Excision with Pericardial Graft: Long-Term Follow Up
2008
Effects of ??1-Adrenoceptor Antagonists on Male Sexual Function
2006
Bladder cancer
2016 Standout
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer
2016 Standout
Inhibitors of cyclic nucleotide phosphodiesterase 3 and 5 as therapeutic agents in heart failure
2006
Intravesical Pharmacotherapy for Non–Muscle-Invasive Bladder Cancer: A Critical Analysis of Currently Available Drugs, Treatment Schedules, and Long-Term Results
2007
Saw Palmetto Extracts for Treatment of Benign Prostatic Hyperplasia
1998
11C-Choline Positron Emission Tomography/Computerized Tomography for Preoperative Lymph-Node Staging in Intermediate-Risk and High-Risk Prostate Cancer: Comparison with Clinical Staging Nomograms
2008
Comparison of complications after radical and partial nephrectomy: results from the National Veterans Administration Surgical Quality Improvement Program
2000
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Molecular mechanisms and pharmacokinetics of phosphodiesterase-5 antagonists
2003
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
Sexual dysfunction in the elderly: age or disease?
2005
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
2013 Standout
Targeting Gold Nanoshells on Silica Nanorattles: a Drug Cocktail to Fight Breast Tumors via a Single Irradiation with Near‐Infrared Laser Light
2011
Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy
2009 Standout
Therapeutic effects of herbal extracts and constituents in animal models of psychiatric disorders
2004 Standout
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 Standout
Phytopharmaceutical and synthetic agents in the treatment of benign prostatic hyperplasia (BPH)
1997
Focal Treatment or Observation of Prostate Cancer: Pretreatment Accuracy of Transrectal Ultrasound Biopsy and T2-weighted MRI
2009
Serenoa repensfor benign prostatic hyperplasia
2009
Preliminary European Results of Local Microwave Hyperthermia and Chemotherapy Treatment in Intermediate or High Risk Superficial Transitional Cell Carcinoma of the Bladder
2004
Cushing's syndrome
2006 Standout
Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP)
2011
A Study of Sexuality and Health among Older Adults in the United States
2007 Standout
Quality of Life in Patients after Long-Term Biochemical Cure of Cushing’s Disease
2005
Local treatments for metastases of renal cell carcinoma: a systematic review
2014
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
2018 Standout
Determinants of Long-Term Survival After Major Surgery and the Adverse Effect of Postoperative Complications
2005 Standout
Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911)
2005
Role of Dynamic Contrast-Enhanced Magnetic Resonance (MR) Imaging and Proton MR Spectroscopic Imaging in the Detection of Local Recurrence after Radical Prostatectomy for Prostate Cancer
2008
Imaging of prostate cancer with PET/CT and radioactively labeled choline derivates
2011
Treatment Options Available for Bacillus Calmette-Guérin Failure in Non–muscle-invasive Bladder Cancer
2012
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
2013 Standout
Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Enlargement
2010
Oncological and functional outcomes of sexual function–preserving cystectomy compared with standard radical cystectomy in men: A systematic review
2017
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
The Management of Peyronie’s Disease: Evidence-based 2010 Guidelines
2010
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Between-Method Differences in Prostate-Specific Antigen Assays Affect Prostate Cancer Risk Prediction by Nomograms
2011
Extracorporeal lithotripsy and combined surgical procedures in the treatment of renoureteral stone disease: Our experience with 2,955 patients
1989
Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women
2014 Standout
Phase II Marker Lesion Study With Intravesical Instillation of Apaziquone for Superficial Bladder Cancer: Toxicity and Marker Response
2006
CHAPTER 1: AUA GUIDELINE ON MANAGEMENT OF STAGHORN CALCULI: DIAGNOSIS AND TREATMENT RECOMMENDATIONS
2005 Standout
The Role of Plant-Derived Drugs and Herbal Medicines in Healthcare
1997
Neoadjuvant Combined Microwave Induced Local Hyperthermia and Topical Chemotherapy Versus Chemotherapy Alone for Superficial Bladder Cancer
1996
Critical Review of Prostate Cancer Predictive Tools
2009
Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil--review of the literature.
2002
Epithelializing Stent for Benign Prostatic Hyperplasia: A Systematic Review of the Literature
2007
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Complementary/Alternative Medicine Use in a Comprehensive Cancer Center and the Implications for Oncology
2000 Standout
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
2011 Standout
Treatment of Ureteral and Renal Stones: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials
2012
Nanoparticles as a Novel Delivery Vehicle for Therapeutics Targeting Erectile Dysfunction
2009
Finasteride for benign prostatic hyperplasia
2010
Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART II
2016 Standout
Biochemistry and Physiology of Cyclic Nucleotide Phosphodiesterases: Essential Components in Cyclic Nucleotide Signaling
2007 Standout
Guideline for Management of the Clinical T1 Renal Mass
2009 Standout
THE CASE FOR LAPAROSCOPIC ADRENALECTOMY
2001
Challenges in Clinical Prostate Cancer: Role of Imaging
2009
Ultrasound Elastography: Review of Techniques and Clinical Applications
2017 Standout
Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents)
2000 Standout
Multicentric Study Comparing Intravesical Chemotherapy Alone and With Local Microwave Hyperthermia for Prophylaxis of Recurrence of Superficial Transitional Cell Carcinoma
2003
The Management of Peyronie's Disease: Evidence-based 2010 Guidelines
2011
Works of P. Rigatti being referenced
Low‐grade left varicocele in patients over 30 years old:the effect of spermatic vein ligation on fertility
2000
A comparison of the efficacy and tolerability of tamsulosin and finasteride in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia
2003
Combination of intravesical chemotherapy and hyperthermia for the treatment of superficial bladder cancer: preliminary clinical experience
2003
Thermo–Chemotherapy and Electromotive Drug Administration of Mitomycin C in Superficial Bladder Cancer Eradication
2001
Cystine Lithiasis: Combined Extracorporeal and Litholytic Treatment
2015
Sildenafil taken at bedtime significantly increases nocturnal erections: results of a placebo-controlled study
2000
Histological and Ultrastructural Evaluation of Extracorporeal ShockWave Lithotripsy-Induced Acute Renal Lesions: Preliminary Report
1989
Current status of local penile therapy
2002
The ageing male and erectile dysfunction
2003
GENITAL PLUS AUDIOVISUAL SEXUAL STIMULATION FOLLOWING INTRACAVERNOUS VASOACTIVE INJECTION VERSUS RE-DOSING FOR ERECTILE DYSFUNCTION-RESULTS OF A PROSPECTIVE STUDY
1998
Pharmacological management of erectile dysfunction
2003
Diagnosis of local recurrence after radical prostatectomy
2004
Intraoperative use of tranexamic acid to reduce transfusion rate in patients undergoing radical retropubic prostatectomy: double blind, randomised, placebo controlled trial
2011
Intravesical electromotive administration of drugs for treatment of superficial bladder cancer: a comparative phase II study
1998
Women's sexual dysfunction: a pathophysiological review
2004
Development and External Validation of an Extended 10-Core Biopsy Nomogram
2006
Combined Intravesical Chemotherapy with Mitomycin C andLocal Bladder Microwave-Induced Hyperthermia as aPreoperative Therapy for Superficial Bladder Tumors
1991
Fifteen-year single-centre experience with three different surgical procedures of nerve-sparing cystectomy in selected organ-confined bladder cancer patients
2015
123 Five year follow-up of plaque incision and vein grafting for Peyronie's disease
2004
Conservative surgery in small renal tumors: our experience.
1999
Ureteral lithiasis: in situ piezoelectric versus in situ spark gap lithotripsy. A randomized study.
1995
280 Results of the randomized trial comparing radical and partial nephrectomy for small kidney neoplasms eortc protocol 30904
2004
The use of wallstents in patients with benign prostatic hyperplasia.
1994
450 COMPLETE METASTASECTOMY IS AN INDEPENDENT PREDICTOR OF CANCER-SPECIFIC SURVIVAL IN PATIENTS WITH CLINICALLY METASTATIC RENAL CELL CARCINOMA
2010
Post-operative radiotherapy (P-RXT) after radical prostatectomy (Px) improves progression-free survival (PFS) in pT3N0 prostate cancer (PC) (EORTC 22911)
2004
HOLMIUM LASER ENUCLEATION OF THE PROSTATE (HOLEP) VERSUS OPEN PROSTATECTOMY FOR PROSTATES > 70 G: 2-YEAR FOLLOW-UP
2006
Laparoscopic bilateral adrenalectomy for persistent Cushing's disease after transsphenoidal surgery
1998
Effects of short-term treatment with the alpha 1-blocker alfuzosin on urodynamic pressure/flow parameters in patients with benign prostatic hyperplasia.
1997
Value of [ 11 C]choline-Positron Emission Tomography for Re-Staging Prostate Cancer: A Comparison With [ 18 F]fluorodeoxyglucose-Positron Emission Tomography
2003
763 LONG-TERM (5 YEARS) OUTCOME OF LAPAROSCOPIC CRYOABLATION FOR RENAL CELL CARCINOMA IN A SINGLE HIGH VOLUME UROLOGICAL DEPARTMENT
2010
Comparative effects of alfuzosin versus Serenoa repens in the treatment of symptomatic benign prostatic hyperplasia.
1995